These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 20371690

  • 1. Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis.
    Koyama M, Izutani Y, Goda AE, Matsui TA, Horinaka M, Tomosugi M, Fujiwara J, Nakamura Y, Wakada M, Yogosawa S, Sowa Y, Sakai T.
    Clin Cancer Res; 2010 Apr 15; 16(8):2320-32. PubMed ID: 20371690
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan 15; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

  • 3. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW, Seo CY, Han H, Han JY, Jeong JS, Kwak JY, Park JI.
    Clin Cancer Res; 2009 Sep 01; 15(17):5414-25. PubMed ID: 19690198
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
    Kondoh K, Tsuji N, Asanuma K, Kobayashi D, Watanabe N.
    Exp Cell Res; 2007 Oct 01; 313(16):3486-96. PubMed ID: 17706193
    [Abstract] [Full Text] [Related]

  • 6. Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21.
    Shen ZN, Nishida K, Doi H, Oohashi T, Hirohata S, Ozaki T, Yoshida A, Ninomiya Y, Inoue H.
    Biochem Biophys Res Commun; 2005 Mar 11; 328(2):375-82. PubMed ID: 15694358
    [Abstract] [Full Text] [Related]

  • 7. Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.
    Denlinger CE, Rundall BK, Jones DR.
    J Thorac Cardiovasc Surg; 2004 Nov 11; 128(5):740-8. PubMed ID: 15514602
    [Abstract] [Full Text] [Related]

  • 8. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
    Liu JD, Lin SY, Ho YS, Pan S, Hung LF, Tsai SH, Lin JK, Liang YC.
    Mol Carcinog; 2003 May 11; 37(1):16-24. PubMed ID: 12720296
    [Abstract] [Full Text] [Related]

  • 9. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state.
    Katura T, Moriya T, Nakahata N.
    Mol Pharmacol; 2010 Apr 11; 77(4):601-11. PubMed ID: 20086036
    [Abstract] [Full Text] [Related]

  • 10. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.
    Yamamoto Y, Fujita M, Koma H, Yamamori M, Nakamura T, Okamura N, Yagami T.
    Biochem Biophys Res Commun; 2011 Jul 08; 410(3):563-7. PubMed ID: 21683069
    [Abstract] [Full Text] [Related]

  • 11. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY, Tseng CC.
    Mol Pharmacol; 2005 Nov 08; 68(5):1203-13. PubMed ID: 16077033
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
    Sung ES, Kim A, Park JS, Chung J, Kwon MH, Kim YS.
    Apoptosis; 2010 Oct 08; 15(10):1256-69. PubMed ID: 20582477
    [Abstract] [Full Text] [Related]

  • 13. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Fulzele SV, Chatterjee A, Shaik MS, Jackson T, Ichite N, Singh M.
    Anticancer Drugs; 2007 Jan 08; 18(1):65-78. PubMed ID: 17159504
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
    Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M.
    Mol Pharmacol; 2007 Nov 08; 72(5):1246-57. PubMed ID: 17673570
    [Abstract] [Full Text] [Related]

  • 15. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S, Yoshida T, Shiraishi T, Horinaka M, Kouhara J, Wakada M, Sakai T.
    Mol Cancer Ther; 2006 Jul 08; 5(7):1827-35. PubMed ID: 16891469
    [Abstract] [Full Text] [Related]

  • 16. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.
    Yokoyama Y, Masaki T, Kiribayashi K, Nakashima A, Kokoroishi K, Ogawa T, Kohno N, Yorioka N.
    Ther Apher Dial; 2010 Feb 08; 14(1):43-51. PubMed ID: 20438519
    [Abstract] [Full Text] [Related]

  • 17. 15-Deoxy-delta 12, 14,-prostaglandin J2 suppresses nuclear factor-kappaB-mediated apoptosis of Helicobacter pylori-infected gastric epithelial cells.
    Cha B, Kim KH, Kim H.
    Ann N Y Acad Sci; 2009 Aug 08; 1171():457-63. PubMed ID: 19723089
    [Abstract] [Full Text] [Related]

  • 18. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
    Emi M, Maeyama K.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1259-67. PubMed ID: 15013841
    [Abstract] [Full Text] [Related]

  • 19. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
    Shi YK, Li ZH, Han XQ, Yi JH, Wang ZH, Hou JL, Feng CR, Fang QH, Wang HH, Zhang PF, Wang FS, Shen J, Wang P.
    Cancer Chemother Pharmacol; 2010 Nov 01; 66(6):1131-40. PubMed ID: 20838997
    [Abstract] [Full Text] [Related]

  • 20. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY, Dai Y, Grant S.
    Clin Cancer Res; 2004 Jun 01; 10(11):3839-52. PubMed ID: 15173093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.